Recombinant Anti-DR5 x Anti-FAP Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/07/07
Country: United States
Summary: Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can be used in pretargeting system of PET, radioimaging or radiotherapy. It can mediate targeting of radioactivity to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors imaging and therapy.https://www.creative-biolabs.com/bsab/symbolsearch-dtpa%2520%2526%2520gd2.htm